Correlation Between Virpax Pharmaceuticals and MiMedx
Can any of the company-specific risk be diversified away by investing in both Virpax Pharmaceuticals and MiMedx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virpax Pharmaceuticals and MiMedx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virpax Pharmaceuticals and MiMedx Group, you can compare the effects of market volatilities on Virpax Pharmaceuticals and MiMedx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virpax Pharmaceuticals with a short position of MiMedx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virpax Pharmaceuticals and MiMedx.
Diversification Opportunities for Virpax Pharmaceuticals and MiMedx
-0.7 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Virpax and MiMedx is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Virpax Pharmaceuticals and MiMedx Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MiMedx Group and Virpax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virpax Pharmaceuticals are associated (or correlated) with MiMedx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MiMedx Group has no effect on the direction of Virpax Pharmaceuticals i.e., Virpax Pharmaceuticals and MiMedx go up and down completely randomly.
Pair Corralation between Virpax Pharmaceuticals and MiMedx
Given the investment horizon of 90 days Virpax Pharmaceuticals is expected to under-perform the MiMedx. In addition to that, Virpax Pharmaceuticals is 2.84 times more volatile than MiMedx Group. It trades about -0.15 of its total potential returns per unit of risk. MiMedx Group is currently generating about -0.19 per unit of volatility. If you would invest 962.00 in MiMedx Group on November 1, 2024 and sell it today you would lose (71.00) from holding MiMedx Group or give up 7.38% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virpax Pharmaceuticals vs. MiMedx Group
Performance |
| Timeline |
| Virpax Pharmaceuticals |
| MiMedx Group |
Virpax Pharmaceuticals and MiMedx Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virpax Pharmaceuticals and MiMedx
The main advantage of trading using opposite Virpax Pharmaceuticals and MiMedx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virpax Pharmaceuticals position performs unexpectedly, MiMedx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MiMedx will offset losses from the drop in MiMedx's long position.| Virpax Pharmaceuticals vs. Revelation Biosciences | Virpax Pharmaceuticals vs. Palisade Bio | Virpax Pharmaceuticals vs. Virax Biolabs Group | Virpax Pharmaceuticals vs. Quoin Pharmaceuticals Ltd |
| MiMedx vs. Monte Rosa Therapeutics | MiMedx vs. Design Therapeutics | MiMedx vs. Werewolf Therapeutics | MiMedx vs. Ikena Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |